Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Cash on Hand 2020–2022
Elicio Therapeutics Inc. annual/quarterly cash on hand history from 2020 to 2022. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Elicio Therapeutics Inc. cash on hand for the quarter ending December 31, 2022 were 6.2M, a 93.06% decrease year-over-year.
- Elicio Therapeutics Inc. cash on hand for 2022 were 6.2M, a 93.06% decrease from 2021.
- Elicio Therapeutics Inc. cash on hand for 2021 were 88.8M, a 156.47% increase from 2020.
- Elicio Therapeutics Inc. cash on hand for 2020 were 34.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Elicio Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2022 | $6 |
| 2021 | $89 |
| 2020 | $35 |
| Elicio Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2022-12-31 | $6 |
| 2021-12-31 | $89 |
| 2020-12-31 | $35 |
Elicio Therapeutics Inc. Cash on Hand — FAQ
Elicio Therapeutics Inc. (ELTX) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELTX's cash on hand history?
The chart and table above show Elicio Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.